Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects

NCT02256488 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1561

Enrollment

INDUSTRY

Sponsor class

Conditions

Prophylaxis: Influenza

Interventions

BIOLOGICAL: TIVc_LOT A
BIOLOGICAL: TIVc_LOT B
BIOLOGICAL: TIVc_LOT C
BIOLOGICAL: TIVf

Sponsor

Novartis Vaccines